Health
New drug class effective in treating certain types of ovarian cancers – News-Medical.Net
A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in…
A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build up a resistance to chemotherapy.
Rucaparib is in a relatively new class of drugs – Poly(ADP-ribose) polymerase or PARP inhibitors – which have been approved for therapy in ovarian cancers. This study provides insights into both how the cancers resist treatments, and which patients…
-
Noosa News23 hours agoState clears the way for farmland on Brisbane fringe to be developed
-
General18 hours agoPrada to buy rival Versace in $2.3 billion deal
-
General17 hours agoUS considering tariff deals with 15 countries: official
-
General23 hours agoAboriginal peak body says NT’s new DV approach ‘risks taking backward step’